Jefferies Initiates Coverage On Twist Bioscience with Hold Rating, Announces Price Target of $150
Jefferies analyst Matthew Stanton initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Hold rating and announces Price Target of $150.
Share
Why It Matters
A big investment bank started watching Twist Bioscience stock. They think it's fairly priced right now, so wait and see.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.